Design and implementation of an adaptive confirmatory trial in Japanese patients with palmoplantar pustulosis
Background/Aims: More and more literature describes how to overcome challenges in the implementation of adaptive designs for trials for drug approval process. Most adaptive trials were conducted in Western Europe or USA for Phase II or Phase II/III settings; however, examples of non-oncology pivotal...
Main Authors: | Richuan Zheng, Yoichi M. Ito, Motonari Yunoki, Kazuki Minoda, Soyoku Nobeyama |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-08-01
|
Series: | Contemporary Clinical Trials Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451865422000527 |
Similar Items
-
Effect of guselkumab on serum biomarkers in Japanese palmoplantar pustulosis patients in a randomized phase 3 study
by: Akimichi Morita, et al.
Published: (2023-03-01) -
Recalcitrant palmoplantar pustulosis controlled with dupilumab
by: Hannah D. Smith, BA, et al.
Published: (2023-05-01) -
Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies
by: Heidemeyer K, et al.
Published: (2023-09-01) -
Refractory Palmoplantar Pustulosis Successfully Treated with JAK Inhibitor Tofacitinib: A Case Series
by: Xu Q, et al.
Published: (2023-08-01) -
Secukinumab-Induced Alopecia Areata Successfully Treated with Tofacitinib in a Patient with Palmoplantar Pustulosis
by: Zhang C, et al.
Published: (2023-10-01)